Aging of platelets stored for transfusion

References

• Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. New Engl J Med 1962;266:905–909.
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol 1978;7(3):523–539.
   PubMedGoogle Scholar
• Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991;338(8777):1223–1226.
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. New Engl J Med 2010;362(7):600–613.
   PubMed Web of Science ®Google Scholar
• Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;66(5):1105–1109.
   PubMed Web of Science ®Google Scholar
• British Committee for Standards in Haematology BTTF. Guidelines for the use of platelet transfusions. Br J Haematol 2003;122:10–23.
   PubMed Web of Science ®Google Scholar
• New HV, Stanworth SJ, Engelfriet CP, Reesink HW, McQuilten ZK, Savoia HF, Savoia HF, Wood EM, Olyntho S, Trigo F, et al. Neonatal transfusions. Vox Sanguinis 2009;96(1):62–85.
   PubMed Web of Science ®Google Scholar
• Slichter SJ. Evidence-based platelet transfusion guidelines. American Society of Hematology Education Program 2007:172–178.
   Google Scholar
• Shah A, Stanworth SJ, McKechnie S. Evidence and triggers for the transfusion of blood and blood products. Anaesthesia 2015;70(Suppl 1):10–9, e3–5.
   Google Scholar
• Sweeney JaL, M. Epidemiology pf platelet transfusion. Bethesda, MD: AABB; 2013.
   Google Scholar
• Morowski M, Vogtle T, Kraft P, Kleinschnitz C, Stoll G, Nieswandt B. Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood 2013;121(24):4938–4947.
   PubMed Web of Science ®Google Scholar
• Patel D, Vaananen H, Jirouskova M, Hoffmann T, Bodian C, Coller BS. Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood 2003;101(3):929–936.
   PubMed Web of Science ®Google Scholar
• Kuijpers MJ, Megens RT, Nikookhesal E, Feijge MA, De Mey JG, oude Egbrink MG, van Giezen JJ, Heemskerk JW. Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y(1)(2) antagonist ticagrelor. Thromb Haemost 2011;106(6):1179–1188.
   Google Scholar
• Adly AA, Ragab IA, Ismail EA, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets 2015;26(7):645–650.
   PubMed Web of Science ®Google Scholar
• Morkis IV, Farias MG, Rigoni LD, Scotti L, Gregianin LJ, Daudt LE, Silla LM, Paz AA. Assessment of immature platelet fraction and immature reticulocyte fraction as predictors of engraftment after hematopoietic stem cell transplantation. Int J Lab Hematol 2015;37(2):259–264.
   PubMed Web of Science ®Google Scholar
• Hong H, Xiao W, Maitta RW. Steady increment of immature platelet fraction is suppressed by irradiation in single-donor platelet components during storage. PLoS One 2014;9(1):e85465.
   PubMedGoogle Scholar
• European Committee on Blood Transfusion: Guide to the preparation, use and quality assurance of blood components. 18th ed. Strasbourg: EDQM; 2015.
   Google Scholar
• FDA-CBER Guidance - Circular of information for the use of human blood and blood components. 2014; 21. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM364593.pdf.
   Google Scholar
• Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370(9585):427–438.
   PubMed Web of Science ®Google Scholar
• Lefrere JJ, Hewitt P. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion 2009;49(4):797–812.
   PubMed Web of Science ®Google Scholar
• Cervia JS, Wenz B, Ortolano GA. Leukocyte reduction’s role in the attenuation of infection risks among transfusion recipients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2007;45(8):1008–1013.
   PubMed Web of Science ®Google Scholar
• Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44(1):16–24.
   PubMed Web of Science ®Google Scholar
• Levitt J, ed. Standards for blood banks and transfusion services. 29 ed. Bethesda, MD: AABB; 2014.
   Google Scholar
• Benjamin RJ, McDonald CP. The international experience of bacterial screen testing of platelet components with an automated microbial detection system: a need for consensus testing and reporting guidelines. Transfus Med Rev 2014;28(2):61–71.
   PubMed Web of Science ®Google Scholar
• Salunkhe V, van der Meer PF, de Korte D, Seghatchian J, Gutierrez L. Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus Apher Sci 2015;52(1):19–34.
   PubMed Web of Science ®Google Scholar
• Prudent M, D’Alessandro A, Cazenave JP, Devine DV, Gachet C, Greinacher A, Lion N, Schubert P, Steil L, Thiele T, et al. Proteome changes in platelets after pathogen inactivation: an interlaboratory consensus. Transf Med Rev 2014;28(2):72–83.
   PubMed Web of Science ®Google Scholar
• Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest 1966;45(5):645–657.
   PubMed Web of Science ®Google Scholar
• Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Transfusion 2006;46(6):973–979.
   PubMed Web of Science ®Google Scholar
• Dowling MR, Josefsson EC, Henley KJ, Kile BT, Hodgkin PD. A model for studying the hemostatic consumption or destruction of platelets. PLoS One 2013;8(3):e57783.
   PubMedGoogle Scholar
• Lance MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 2015;13:1.
   PubMedGoogle Scholar
• Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. The Cochrane Database of Systematic Reviews 2011(3):CD007871.
   Google Scholar
• Vostal JG. Efficacy evaluation of current and future platelet transfusion products. J Trauma 2006;60(6 Suppl):S78–S82.
   PubMedGoogle Scholar
• Murphy S. The case for a new approach for documenting platelet viability. Transfusion 2006;46:49S–52S.
   Google Scholar
• BEST Collaborative: Platelet radiolabeling procedure. Transfusion 2006;46:59S–66S.
   Google Scholar
• Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. BEST/ISBT. Transfusion 1998;38(1):31–40.
   PubMed Web of Science ®Google Scholar
• VandenBroeke T, Dumont LJ, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon JP, Gulliksson H, Dengler T, et al. Platelet storage solution affects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sanguinis 2004;86(3):183–188.
   PubMed Web of Science ®Google Scholar
• Murphy S. What’s so bad about old platelets? Transfusion 2002;42(7):809–811.
   PubMed Web of Science ®Google Scholar
• Pearson TC, Guthrie DL, Simpson J, Chinn S, Barosi G, Ferrant A, Lewis SM, Najean Y. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the ICSH. Br J Haematol 1995;89(4):748–756.
   PubMed Web of Science ®Google Scholar
• Nydegger UE, Luginbuhl M, Risch M. The aging human recipient of transfusion products. Transfus Apher Sci 2015;52(3):290–294.
   PubMed Web of Science ®Google Scholar
• Estcourt LJ, Crighton GL, Wood EM, Stanworth S, Trivella M, Doree C, Tinmouth A, Murphy MF. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. The Cochrane Database of Systematic Reviews 2014;(3) pii: CD010981.
   Web of Science ®Google Scholar
• Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. New Engl J Med 2013;368(19):1771–1780.
   PubMed Web of Science ®Google Scholar
• FDA CBER Blood Products Advisory Committee 76th Meeting. Gaithersburg, MD. 2003. Available from: http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3940t1.htm and http://www.fda.gov/ohrms/dockets/ac/03/transcripts/3940t2.htm.
   Google Scholar
• Slichter SJ, Bolgiano D, Jones MK, Christoffel T, Corson J, Rose L, Foley J, Popovsky M, Baril LL, Corda T, et al. Viability and function of 8-day-stored apheresis platelets. Transfusion 2006;46(10):1763–1769.
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T, Pellham E. Extended storage of autologous apheresis platelets in plasma. Vox Sanguinis 2013;104(4):324–330.
   PubMed Web of Science ®Google Scholar
• MacLennan S, Harding K, Llewelyn C, Choo L, Bakrania L, Massey E, Stanworth S, Pendry K, Williamson LM. A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2- to 5- versus 6- or 7-day-stored platelets. Transfusion 2015;55(8):1856–1865; quiz 5.
   PubMed Web of Science ®Google Scholar
• Diedrich B, Ringden O, Watz E, Shanwell A. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients. Vox Sanguinis 2009;97(3):254–259.
   PubMed Web of Science ®Google Scholar
• Heuft HG, Goudeva L, Krauter J, Peest D, Buchholz S, Tiede A. Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation. Vox Sanguinis 2013;105(1):18–27.
   PubMed Web of Science ®Google Scholar
• Prowse CV. Component pathogen inactivation: a critical review. Vox Sanguinis 2013;104(3):183–199.
   PubMed Web of Science ®Google Scholar
• Mirasol Clinical Evaluation Study Group: a randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010;50(11):2362–2375.
   PubMed Web of Science ®Google Scholar
• McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104(5):1534–1541.
   PubMed Web of Science ®Google Scholar
• Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG; SPRINT Study Group. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion 2006;46(1):24–33.
   PubMed Web of Science ®Google Scholar
• Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011;51(8):1676–1683.
   PubMed Web of Science ®Google Scholar
• Savage WJ, Tobian AA, Savage JH, Wood RA, Schroeder JT, Ness PM. Scratching the surface of allergic transfusion reactions. Transfusion 2013;53(6):1361–1371.
   PubMed Web of Science ®Google Scholar
• Stolla M, Refaai MA, Heal JM, Spinelli SL, Garraud O, Phipps RP, Blumberg N. Platelet transfusion: the new immunology of an old therapy. Front Immunol 2015;6:28.
   PubMed Web of Science ®Google Scholar
• Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG; SPRINT Study Group. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 2005;45(12):1864–1875.
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at “room temperature”. Transfusion 1975;15(5):414–421.
   PubMed Web of Science ®Google Scholar
• Hirayama J, Azuma H, Fujihara M, Akino M, Homma C, Kato T, Ikeda H. Comparison between in vitro qualities of platelets washed with commercially available additive solutions and those washed with M-sol. Vox Sanguinis 2010;99(2):131–135.
   PubMed Web of Science ®Google Scholar
• Bertolini F, Agazzi A, Peccatori F, Martinelli G, Sandri MT. The absence of swirling in platelet concentrates is highly predictive of poor posttransfusion platelet count increments and increased risk of a transfusion reaction. Transfusion 2000;40(1):121–122.
   PubMed Web of Science ®Google Scholar
• Edenbrandt CM, Murphy S. Adenine and guanine nucleotide metabolism during platelet storage at 22 degrees C. Blood 1990;76(9):1884–1892.
   PubMed Web of Science ®Google Scholar
• Murphy S. Metabolic patterns of platelets: impact on storage for transfusion. Vox Sanguinis 1994;67:271–273.
   PubMed Web of Science ®Google Scholar
• Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sanguinis 2006;90(4):279–285.
   PubMed Web of Science ®Google Scholar
• Dumont LJ, AuBuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative. Transfusion 2006;46(8):1300–1305.
   PubMed Web of Science ®Google Scholar
• Curvers J, de Wildt-Eggen J, Heeremans J, Scharenberg J, de Korte D, van der Meer PF. Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort. Transfusion 2008;48(7):1439–1446.
   PubMed Web of Science ®Google Scholar
• Nguyen KA, Hamzeh-Cognasse H, Palle S, Anselme-Bertrand I, Arthaud CA, Chavarin P, Pozzetto B, Garraud O, Cognasse F. Role of Siglec-7 in apoptosis in human platelets. PLoS One 2014;9(9):e106239.
   PubMedGoogle Scholar
• Jansen AJ, Josefsson EC, Rumjantseva V, Liu QP, Falet H, Bergmeier W, Cifuni SM, Sackstein R, von Andrian UH, Wagner DD, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbalpha metalloproteinase-mediated cleavage in mice. Blood 2012;119(5):1263–1273.
   PubMed Web of Science ®Google Scholar
• Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, Paré A, Rousseau M, Naika GS, Lévesque T, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014;124(14):2173–2183.
   PubMed Web of Science ®Google Scholar
• Johnson L, Schubert P, Tan S, Devine DV, Marks DC. Extended storage and glucose exhaustion are associated with apoptotic changes in platelets stored in additive solution. Transfusion 2016;56(2):360–368.
   PubMed Web of Science ®Google Scholar
• Rumjantseva V, Hoffmeister KM. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010;42(1):63–70.
   PubMed Web of Science ®Google Scholar
• Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, Hoffmeister KM. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nature Med 2015;21(1):47–54.
   PubMed Web of Science ®Google Scholar
• Kostelijk EH, Folman CC, Gouwerok CW, Kramer CM, Verhoeven AJ, de Korte D. Increase in glycocalicin levels in platelet concentrates stored in plasma or synthetic medium for 8 days: comparison with other platelet activation markers. Vox Sanguinis 2000;79(1):21–26.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Andrews RK. Platelet receptor expression and shedding: Glycoprotein Ib-IX-V and Glycoprotein VI. Transfus Med Rev 2014;28(2):56–60.
   PubMed Web of Science ®Google Scholar
• Javela K, Eronen J, Sarna S, Kekomaki R. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation. Transfusion 2005;45(9):1504–1511.
   PubMed Web of Science ®Google Scholar
• Azorsa DO, Moog S, Ravanat C, Schuhler S, Follea G, Cazenave JP, Lanza F. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA–its use to follow platelet storage in transfusion. Thromb Haemost 1999;81(1):131–138.
   PubMed Web of Science ®Google Scholar
• Jilma-Stohlawetz P, Mannhalter C, Kaider A, Waidacher T, Jilma B, Panzer S. The association of the Thr715Pro P-selectin genotype with levels of P-selectin in platelet concentrates. Vox Sanguinis 2014;107(4):368–374.
   PubMed Web of Science ®Google Scholar
• Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003;43(4):526–535.
   PubMed Web of Science ®Google Scholar
• Albanyan AM, Harrison P, Murphy MF. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Transfusion 2009;49(1):108–117.
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mutlu A, Mykhaylov S, Lyubimov E, Freedman J. Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. Br J Haematol 2008;142(3):494–497.
   PubMed Web of Science ®Google Scholar
• Cookson P, Sutherland J, Turner C, Bashir S, Wiltshire M, Hancock V, Smith K, Cardigan R. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution. Transfus Med (Oxford, England) 2010;20(6):392–402.
   PubMed Web of Science ®Google Scholar
• Perales Villarroel JP, Figueredo R, Guan Y, Tomaiuolo M, Karamercan MA, Welsh J, Selak MA, Becker LB, Sims C. Increased platelet storage time is associated with mitochondrial dysfunction and impaired platelet function. J Surg Res 2013;184(1):422–429.
   PubMed Web of Science ®Google Scholar
• Skripchenko A, Awatefe H, Thompson-Montgomery D, Myrup A, Turgeon A, Wagner SJ. An inhibition of p38 mitogen activated protein kinase delays the platelet storage lesion. PLoS One 2013;8(8):e70732.
   PubMedGoogle Scholar
• van der Wal DE, Du VX, Lo KS, Rasmussen JT, Verhoef S, Akkerman JW. Platelet apoptosis by cold-induced glycoprotein Ibalpha clustering. J Thromb Haemost: JTH 2010;8(11):2554–2562.
   PubMed Web of Science ®Google Scholar
• Chen Z, Schubert P, Culibrk B, Devine DV. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Transfusion 2015;55(4):848–857.
   PubMed Web of Science ®Google Scholar
• Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion 2003;43(7):857–866.
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Hoffmeister KM, Hu Z, Mager DE, Ait-Oudhia S, Debrincat MA, Pleines I, Josefsson EC, Kile BT, Italiano J, et al. Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan. Blood 2014;123(22):3381–3389.
   PubMed Web of Science ®Google Scholar
• Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability: deleterious effect of refrigerated storage. New Engl J Med 1969;280(20):1094–1098.
   PubMed Web of Science ®Google Scholar
• van der Wal DE, Gitz E, Du VX, Lo KS, Koekman CA, Versteeg S, Akkerman JW. Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Ibalpha–14-3-3zeta] association. Haematologica 2012;97(10):1514–1522.
   PubMed Web of Science ®Google Scholar
• Skripchenko A, Gelderman MP, Awatefe H, Turgeon A, Thompson-Montgomery D, Cheng C, Vostal JG, Wagner SJ. Automated cold temperature cycling improves in vitro platelet properties and in vivo recovery in a mouse model compared to continuous cold storage. Transfusion 2016;56(1):24–32.
   PubMed Web of Science ®Google Scholar
• Akkerman JW, Verhgoeven, AJM. Energy metabolism and function. In: Platelet responses and metabolism. Holmsen H, editor. Boca Raton, FL: CRC Press; 1987.
   Google Scholar
• Holme S, Heaton A. In vitro platelet ageing at 22 degrees C is reduced compared to in vivo ageing at 37 degrees C. Br J Haematol 1995;91(1):212–218.
   PubMed Web of Science ®Google Scholar
• Guppy M, Abas L, Neylon C, Whisson ME, Whitham S, Pethick DW, Niu X. Fuel choices by human platelets in human plasma. Eur J Biochem/FEBS 1997;244(1):161–167.
   PubMedGoogle Scholar
• Holme S. Platelet storage lesions and metabolism: are apoptotic and necrotic processes involved? In: Platelet Transfusion Therapy. Sweeney JD, Lozano M (eds). Bethesda, MD: AABB Press; 2013.
   Google Scholar
• Vaughn AE, Deshmukh M. Glucose metabolism inhibits apoptosis in neurons and cancer cells by redox inactivation of cytochrome c. Nat Cell Biol 2008;10(12):1477–1483.
   PubMed Web of Science ®Google Scholar
• Wagner SJ. The maintenance of platelet properties during 20–24 degrees C storage after periods of shipment or interrupted agitation. Transfus Apher Sci 2010;42(1):45–51.
   PubMed Web of Science ®Google Scholar
• Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev 2009;89(1):193–277.
   PubMed Web of Science ®Google Scholar
• Rinder HM, Snyder EL, Tracey JB, Dincecco D, Wang C, Baril L, Rinder CS, Smith BR. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003;43(9):1230–1237.
   PubMed Web of Science ®Google Scholar
• Gulliksson H. Platelet storage media. Vox Sanguinis 2014;107(3):205–212.
   PubMed Web of Science ®Google Scholar
• Murphy S, Kahn RA, Holme S, Phillips GL, Sherwood W, Davisson W, Buchholz DH. Improved storage of platelets for transfusion in a new container. Blood 1982;60(1):194–200.
   PubMed Web of Science ®Google Scholar
• Leytin V, Allen DJ, Mykhaylov S, Mis L, Lyubimov EV, Garvey B, Freedman J. Pathologic high shear stress induces apoptosis events in human platelets. Biochem Biophys Res Commun 2004;320(2):303–310.
   PubMed Web of Science ®Google Scholar
• Gitz E, Koekman CA, van den Heuvel DJ, Deckmyn H, Akkerman JW, Gerritsen HC, Urbanus RT. Improved platelet survival after cold storage by prevention of glycoprotein Ibalpha clustering in lipid rafts. Haematologica 2012;97(12):1873–1881.
   PubMed Web of Science ®Google Scholar
• Bode AP, Orton SM, Frye MJ, Udis BJ. Vesiculation of platelets during in vitro aging. Blood 1991;77(4):887–895.
   PubMed Web of Science ®Google Scholar
• Bryckaert M, Rosa JP, Denis CV, Lenting PJ. Of von Willebrand factor and platelets. Cell Mol Life Sci: CMLS 2015;72(2):307–326.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang W, Yan R, Liao Y, Zhao L, Ruan C, Du X, Dai K. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Circulation Research 2009;105(12):1177–1185.
   PubMed Web of Science ®Google Scholar
• Cranmer SL, Ashworth KJ, Yao Y, Berndt MC, Ruggeri ZM, Andrews RK, Jackson SP. High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbalpha-filamin interaction. Blood 2011;117(9):2718–2727.
   PubMed Web of Science ®Google Scholar
• Skripchenko A, Kurtz J, Moroff G, Wagner SJ. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage. Transfusion 2008;48(7):1469–1477.
   PubMed Web of Science ®Google Scholar
• Levin E, Jenkins C, Culibrk B, Gyongyossy-Issa MI, Serrano K, Devine DV. Development of a quality monitoring program for platelet components: a report of the first four years’ experience at Canadian Blood Services. Transfusion 2012;52(4):810–818.
   PubMed Web of Science ®Google Scholar
• Sandgren P, Diedrich B. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function. Vox Sanguinis 2015;108(4):340–349.
   PubMed Web of Science ®Google Scholar
• Wagner SJ, Skripchenko A, Myrup A, Awatefe H, Thompson-Montgomery D, Moroff G, Carmichael P, Lin L. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light. Transfusion 2009;49(4):704–710.
   PubMed Web of Science ®Google Scholar
• Janetzko K, Hinz K, Marschner S, Goodrich R, Kluter H. Pathogen reduction technology (Mirasol) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS. Vox Sanguinis 2009;97(3):234–239.
   PubMed Web of Science ®Google Scholar
• van der Meer PF, Bontekoe IJ, Daal BB, de Korte D. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution? Transfusion 2015;55(8):1900–1908.
   PubMed Web of Science ®Google Scholar
• Zeddies S, De Cuyper IM, van der Meer PF, Daal BB, de Korte D, Gutierrez L, Thijssen-Timmer DC. Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro. Transfusion 2014;54(9):2292–2300.
   PubMed Web of Science ®Google Scholar
• Hechler B, Ohlmann P, Chafey P, Ravanat C, Eckly A, Maurer E, Mangin P, Isola H, Cazenave JP, Gachet C. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Transfusion 2013;53(6):1187–1200.
   PubMed Web of Science ®Google Scholar
• Thon JN, Devine DV. Translation of glycoprotein IIIa in stored blood platelets. Transfusion 2007;47(12):2260–2270.
   PubMed Web of Science ®Google Scholar
• Kirschbaum M, Karimian G, Adelmeijer J, Giepmans BN, Porte RJ, Lisman T. Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation. Blood 2015;126(6):798–806.
   PubMed Web of Science ®Google Scholar
• Pontes TB, Moreira-Nunes Cde F, Maues JH, Lamarao LM, de Lemos JA, Montenegro RC, Burbano RM. The miRNA profile of platelets stored in a blood bank and its relation to cellular damage from storage. PLoS One 2015;10(6):e0129399.
   PubMedGoogle Scholar
• Osman A, Hitzler WE, Meyer CU, Landry P, Corduan A, Laffont B, Hellstern P, Vamvakas EC, Provost P. Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets 2015;26(2):154–163.
   PubMed Web of Science ®Google Scholar
• Bode AP, Holme S, Heaton WA, Swanson MS. Sustained elevation of intracellular cyclic 3′-5′ adenosine monophosphate is necessary for preservation of platelet integrity during long-term storage at 22 degrees C. Blood 1994;83(5):1235–1243.
   PubMed Web of Science ®Google Scholar
• Schubert P, Thon JN, Walsh GM, Chen CH, Moore ED, Devine DV, Kast J. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009;49(9):1944–1955.
   PubMed Web of Science ®Google Scholar
• Devine DV, Serrano K. The platelet storage lesion. Clinics in Laboratory Medicine 2010;30(2):475–487.
   PubMed Web of Science ®Google Scholar
• Heaton W. In-vivo predictive value of in-vitro platelet testing. In: Platelet Transfusion Therapy. Sweeney JD, Lozano M (eds.). Bethesda, MD: AABB; 2013.
   Google Scholar
• Murphy S. Utility of in vitro tests in predicting the in vivo viability of stored PLTs. Transfusion 2004;44(4):618–619; author reply 9.
   PubMed Web of Science ®Google Scholar
• Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T, Bailey SL, Pellham E. Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution. Transfusion 2014;54(9):2283–2291.
   PubMed Web of Science ®Google Scholar
• Dowling MR, Josefsson EC, Henley KJ, Hodgkin PD, Kile BT. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood 2010;116(10):1776–1778.
   PubMed Web of Science ®Google Scholar
• Wang J, Yi X, Liu M, Zhou Q, Ren S, Wang Y, Yang C, Zhou J, Han Y. Correlation between the in vitro functionality of stored platelets and the cytosolic esterase-induced fluorescence intensity with CMFDA. PLoS One 2015;10(9):e0138509.
   PubMedGoogle Scholar
• Slichter SJ, Corson J, Jones MK, Christoffel T, Pellham E, Bailey SL, Bolgiano D. Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Blood 2014;123(2):271–280.
   PubMed Web of Science ®Google Scholar
• Bautista AP, Buckler PW, Towler HM, Dawson AA, Bennett B. Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets. Br J Haematol 1984;58(4):679–687.
   PubMed Web of Science ®Google Scholar
• Ilyin IY, Tkachman MG, Urusova ME, Jones JS, Grieshober WE, Kogan S, et al. Storage of platelets under pressure with xenon containing atmosphere. Google Patents; 2014.
   Google Scholar
• Badlou BA, van der Meer PF, Akkerman JW, Smid WM, Pietersz RN. Metabolic energy reduction by glucose deprivation and low gas exchange preserves platelet function after 48 h storage at 4 degrees C. Vox Sanguinis 2007;92(4):311–318.
   PubMed Web of Science ®Google Scholar
• Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014;54(8):1917–1926.
   PubMed Web of Science ®Google Scholar
• Reddoch KM, Pidcoke HF, Montgomery RK, Fedyk CG, Aden JK, Ramasubramanian AK, Cap AP. Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock (Augusta, Ga) 2014;41(Suppl 1):54–61.
   PubMed Web of Science ®Google Scholar
• Montgomery RK, Reddoch KM, Evani SJ, Cap AP, Ramasubramanian AK. Enhanced shear-induced platelet aggregation due to low-temperature storage. Transfusion 2013;53(7):1520–1530.
   PubMed Web of Science ®Google Scholar
• Pidcoke HF, Spinella PC, Ramasubramanian AK, Strandenes G, Hervig T, Ness PM, Cap AP. Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards. Shock (Augusta, Ga) 2014;41(Suppl 1):51–53.
   PubMed Web of Science ®Google Scholar
• Dumont LJ, Slichter SJ, Reade MC. Cryopreserved platelets: frozen in a logjam? Transfusion 2014;54(8):1907–1910.
   PubMed Web of Science ®Google Scholar
• Li R, Hoffmeister KM, Falet H. Glycans and the platelet life cycle. Platelets 2016; doi:10.3109/09537104.2016.1171304 [epub ahead of print].
   Google Scholar
• Lebois M, Josefsson EC. Regulation of platelet lifespan by apoptosis. Platelets 2016; doi:10.3109/09537104.2016.1161739 [epub ahead of print].
   Google Scholar